SAM #FY26-0778-1

Sole Source Procurement: Illumina NextSeq 1000 Sequencing System and Support for AFMES DNA Operations

This opportunity involves the planned sole source procurement of a high-throughput DNA sequencing system and associated services for the Armed Forces Medical Examiner System DNA Operations (AFMES-DNA OPS) under the Department of Defense. - Government Buyer: - Department of Defense - Armed Forces Medical Examiner System (AFMES) DNA Operations - Defense Health Agency Contracting Activity (DHACA) - OEM Highlight: - Illumina, Inc. is the only OEM specified and is considered the sole source for this requirement - Products Requested: - Illumina NextSeq 1000 Sequencing System (1 unit) - Next-generation sequencing platform with XLEAP-SBS chemistry - Supports flexible read lengths (2x50 bp to 2x300 bp), up to 120 Gb output per run, 400 million single reads per run - Integrated reagent cartridge, touchscreen interface, RFID tracking, upgrade path to NextSeq 2000 - Includes instrument control computer (Linux OS, 288 GB RAM, 3.8 TB SSD) - Includes all necessary accessories, onboard control software, and XLEAP-SBS reagent and consumable kits - Services Requested: - Three-year Silver Support Plan (extended warranty/support) following the initial one-year manufacturer warranty - Manufacturer-certified installation and Installation Qualification/Operational Qualification (IQ/OQ) - Training on operation, software, maintenance, and Laboratory Information Management System (LIMS) integration - Unique/Notable Requirements: - System must be backward compatible with existing forensic assays - Must support increased mission sample workload for identifying missing service members - Must provide an upgrade path to the NextSeq 2000 - Only Illumina, Inc. is considered technically acceptable; no alternatives are permitted - Installation, qualification, and training must be performed by manufacturer-certified personnel

Description

The Defense Health Agency Contracting Activity (DHACA) in Fort Detrick, MD intends to negotiate on a sole source basis (IAW RFO 12.102(a)) with ILLUMINA, INC 5200 Illumina Way, San Diego, CA 9212-4616 as the only responsible source that can provide the NextSeq 1000 Sequencing System. This is a Presolicitation notice in accordance with RFO 5.101.

The equipment provided by ILLUMINA INC is the only source that provides DHACA with the NextSeq 1000 Sequencing System and extended warranty used at the Armed Forces Medical Examiner System DNA Operations (AFMES-DNA OPS) to support their mission. Its fast, integrated DNA-to-analysis workflow allows for the rapid sequencing of targeted panels, whole mitochondrial genomes, and supports single nucleotide polymorphism (SNP) analysis in a single run.  The extended warranty shall commence when 12-month Manufacturer Warranty expires.

This acquisition is being conducted under simplified acquisition procedures. There are no set-aside restrictions for this requirement. The intended procurement will be classified under North American Industry Classification System (NAICS) 334516 with a Small Business Size Standard of 1,000 employees. This presolicitation notice is not a request for competitive proposals and no solicitation document exists for this requirement. However, any parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same service. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Based on the above information, the only technically acceptable subscription can be provided by ILLUMINA INC . Submit email capability statements (using PDF, MS Word, Excel attachments) to Alicia Maldonado Torres at alicia.maldonadotorres.civ@health.mil. Statements are due no later than 09:00 AM EST on 13 July 2026

View original listing